Vascular Endothelial Growth Factor Receptor-1 D3 Human Recombinant, His Tag, FLT1 D3 Human, His, 10ug

CAT No.BT-PKA-338

Vascular Endothelial Growth Factor Receptor-1 D3 Human Recombinant, His Tag, FLT1 D3 Human, His, 10ug

---

Description
FLT1 D1-3 Human Recombinant produced in baculovirus is monomeric, glycosylated, polypeptide containing 298 amino acids fragment (31-328) and having a molecular mass of 38.16kDa. The receptor protein contains only the first 3 extracellular domains, which contain all the information necessary for binding of VEGF.
The FLT1 is purified by proprietary chromatographic techniques.

Formulation
FLT1 His (0.96mg/ml) is supplied in 25mM Na-Acetate pH 4.8 and 50% glycerol.

Physical Appearance
Sterile Filtered clear solution.

Greater than 95.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.

Source
Insect Cells.

Stability
Store at 4¡ãC if entire vial will be used within 2-4 weeks.
Store, frozen at -20¡ãC for longer periods of time.
Please avoid freeze thaw cycles.

Synonyms
FLT-1, FLT1, Tyrosine-protein kinase receptor FLT, Flt-1, Tyrosine-protein kinase FRT, Fms-like tyrosine kinase 1, VEGFR-1.

Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

Biological activity
Specific activity: > 5.0 unit/mg. One unit will form 1.0 umol of phospho (enol) pyruvate to pyruvate per minute at pH 7.5 at 37C.